SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-12-011173
Filing Date
2012-07-03
Accepted
2012-07-03 17:49:39
Documents
1
Period of Report
2012-06-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 12167
  Complete submission text file 0001179110-12-011173.txt   13483
Mailing Address 4140 DUBLIN BLVD STE 200 DUBLIN CA 94568
Business Address 4140 DUBLIN BLVD SUITE 200 DUBLIN CA 94568 9255600100
Astex Pharmaceuticals, Inc (Issuer) CIK: 0000919722 (see all company filings)

IRS No.: 911841574 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address
Business Address
LACK WALTER J (Reporting) CIK: 0001207708 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27628 | Film No.: 12946342